MedPath

To study the effect of Omega-3 fatty acids on outcome of liver transplant patient

Not Applicable
Conditions
Health Condition 1: K746- Other and unspecified cirrhosis ofliver
Registration Number
CTRI/2019/01/016915
Lead Sponsor
Institute of liver and biliary sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All elective liver transplant recipients

Adult patients

Those who consent

Exclusion Criteria

Liver transplantation for fulminant hepatic failure

Re-transplantation

Known allergy to the study emulsion

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the effect of omega-3 fatty acids supplementation on recipients in LDLT and correlation with early allograft dysfunctionTimepoint: Post operative day 7
Secondary Outcome Measures
NameTimeMethod
Duration of hospital stayTimepoint: Till discharge;Duration of ICU stayTimepoint: Till discharge;Post-operative complicationsTimepoint: Till discharge;To study the correlation between supplementation of omega-3 fatty acids and trend in post-operative LFTsTimepoint: Till discharge;To study the effect of Omega-3 fatty acids supplementation on liver regeneration by CT volumetryTimepoint: Post operative day 7
© Copyright 2025. All Rights Reserved by MedPath